Skip to main content

Table 4 Validation data for the HPLC analysis of ROS and GLM in spiked human plasma.

From: Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma

Parameters Concentration added (μg/mL) Concentration found (μg/mL) % Found
   ROS GLM ROS GLM ROS GLM
Intra-day precision   0.5 0.5 0.4794 0.5033 95.88 100.66
   0.75 0.75 0.7282 0.7157 97.09 95.43
   1.0 1.0 1.0013 0.9821 100.13 98.21
  ( x ¯ )      97.70 98.10
  ± S.D.      2.19 2.62
  %RSD      2.24 2.67
  %Error      1.29 1.54
Inter-day precision 1st day 0.5 0.5 0.4769 0.459 95.38 91.80
  2nd day 0.75 0.75 0.7457 0.719 99.43 95.87
  3rd day 1.0 1.0 0.9677 0.939 96.77 93.90
  ( x ¯ )      97.19 93.86
  ± S.D.      2.05 2.04
  %RSD      2.11 2.04
  %Error      1.22 1.18